Page last updated: 2024-10-26

ethoxzolamide and Bone Loss, Osteoclastic

ethoxzolamide has been researched along with Bone Loss, Osteoclastic in 2 studies

Ethoxzolamide: A carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia.
ethoxzolamide : A sulfonamide that is 1,3-benzothiazole-2-sulfonamide which is substituted by an ethoxy group at position 6. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hall, TJ1
Higgins, W1
Tardif, C1
Chambers, TJ1
Raisz, LG1
Simmons, HA1
Thompson, WJ1
Shepard, KL1
Anderson, PS1
Rodan, GA1

Other Studies

2 other studies available for ethoxzolamide and Bone Loss, Osteoclastic

ArticleYear
A comparison of the effects of inhibitors of carbonic anhydrase on osteoclastic bone resorption and purified carbonic anhydrase isozyme II.
    Calcified tissue international, 1991, Volume: 49, Issue:5

    Topics: Acetazolamide; Bone Resorption; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dimethyl Sulfoxi

1991
Effects of a potent carbonic anhydrase inhibitor on bone resorption in organ culture.
    Endocrinology, 1988, Volume: 122, Issue:3

    Topics: Acetazolamide; Animals; Bone and Bones; Bone Resorption; Calcitriol; Calcium Radioisotopes; Carbon D

1988